France / CIS 69753527

GEMCITABINE ARROW 40 mg/mL, solution à diluer pour perfusion

solution à diluer pour perfusion · intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution à diluer pour perfusion
Routeintraveineuse
Ingredient entries2
CountryFrance

Product identity

At a glance

Authorisation holder
EUGIA PHARMA (MALTA) (MALTE)
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 69753527

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for GEMCITABINE ARROW 40 mg/mL, solution à diluer pour perfusion
IngredientStrength / referenceSource role
GEMCITABINEsolution40 mg1 ml de solution à diluer pour perfusionFTGroup 1
CHLORHYDRATE DE GEMCITABINEsolution45,6 mg1 ml de solution à diluer pour perfusionSAGroup 1

Pack references

Presentations (3)

1 flacon(s) en verre de 5 ml

CIP13 3400957707606

Présentation active · Déclaration de commercialisation
1 flacon(s) en verre de 25 ml

CIP13 3400957707774

Présentation active · Déclaration de commercialisation
1 flacon(s) en verre de 50 ml

CIP13 3400957707835

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 69753527 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →